A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

NCT07668388 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: UBT251
DRUG: UBT251 Placebo
DRUG: Semaglutide
DRUG: Semaglutide Placebo

Sponsor

Novo Nordisk A/S